Obiettivo
The objective of this Integrated Project Genostem is to establish a European international scientific leadership for stem cell regenerative medicine in the field of connective tissue disorders. Autologous adult Mesenchymal Stem Cells (MSCs) are optimal candidates to serve as the building blocks for the engineering of connective tissues being multipotential stem cells that give rise to osteoblasts, chondrocytes and tenocytes, muscle cells and adipocytes. Genostem will compare different tissue sources of MSCs and isolate subsets in order to obtain undifferentiated MSCs, committed MSCs at early stage of differentiation, progeny blocked at specific differentiation stage and fully differentiated progeny. Genostem will study the complete MSC gene product repertoire using genomic and proteomic analysis that should provide with the molecules and pathways potentially operative for the maintenance and differentiation of stem cells. Genostem will develop innovative technologies to generate biodegradable matrices, scaffolds and microcarriers that bind pharmacologically active proteins and allow their delivery in a controlled way; these biomaterials will allow engineering MSCs such as to obtain optimal repair of the target injured tissue. Genostem will improve methods for gene transfer using original virus or non-viral delivery systems in order to carry out gain (gene transfer) and loss (siRNA transfer) of function studies. Genostem will develop transplantation models of MSCs mimicking human pathological processes operative in bone cartilage and tendon diseases. The final goal is to develop clinical trials using MSCs, in bone, cartilage and tendon disorders, in partnership with SMEs and regulatory bodies for the scale up of safe procedures, taking advantage of the experience already acquired by one of the partner in clinical trials using cultured muscle cells.
Campo scientifico
- medical and health sciencesmedical biotechnologygenetic engineeringgene therapy
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health sciencesclinical medicinetransplantation
- engineering and technologyindustrial biotechnologybiomaterials
Argomento(i)
Invito a presentare proposte
FP6-2002-LIFESCIHEALTH
Vedi altri progetti per questo bando
Meccanismo di finanziamento
IP - Integrated ProjectCoordinatore
PARIS
Francia
Mostra sulla mappa
Partecipanti (23)
JERUSALEM
Mostra sulla mappa
TIMISOARA
Mostra sulla mappa
RENNES
Mostra sulla mappa
MIRIBEL
Mostra sulla mappa
BRAUNSCHWEIG
Mostra sulla mappa
MÜNCHEN
Mostra sulla mappa